Structure Therapeutics Ownership | Who Owns Structure Therapeutics?

Structure Therapeutics Ownership Summary

Structure Therapeutics is owned by 92.99% institutional investors, 2.85% insiders, and 4.16% retail investors. Fmr is the largest institutional shareholder, holding 14.20% of GPCR shares. Vanguard Health Care Inv is the top mutual fund, with 4.09% of its assets in Structure Therapeutics shares.

GPCR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Structure Therapeutics	92.99%	2.85%	4.16%
Sector	Healthcare Stocks	244.37%	12.11%	-156.48%
Industry	Biotech Stocks	379.01%	11.75%	-290.76%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	8.40M	14.20%	$405.05M
Wellington management group llp	7.26M	12.26%	$349.95M
Avoro capital advisors	6.56M	11.07%	$315.98M
Ra capital management	1.52M	7.91%	$42.49M
Deep track capital, lp	4.28M	7.23%	$206.29M
Bvf inc/il	3.46M	5.84%	$166.74M
Morgan stanley	2.31M	3.89%	$111.12M
Price t rowe associates inc /md/	2.00M	3.38%	$96.43M
Principal financial group	1.75M	2.96%	$84.53M
Driehaus capital management	1.58M	2.66%	$76.03M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bvf inc/il	3.46M	5.31%	$166.74M
B group	127.50K	4.56%	$6.15M
Casdin capital	1.18M	4.29%	$56.63M
Deep track capital, lp	4.28M	3.37%	$206.29M
Avoro capital advisors	6.56M	3.11%	$315.98M
Birchview capital, lp	100.00K	2.74%	$4.82M
Catalio capital management, lp	255.38K	2.57%	$12.31M
Stempoint capital lp	200.27K	1.88%	$9.65M
Rock springs capital management lp	640.22K	1.82%	$30.86M
Siren	1.33M	1.78%	$64.04M

Top Buyers

Holder	Shares	% Assets	Change
American century companies	1.44M	0.04%	931.07K
Principal financial group	1.75M	0.05%	469.55K
Price t rowe associates inc /md/	2.00M	0.01%	329.56K
Orbimed advisors	1.48M	1.42%	313.60K
Siren	1.33M	1.78%	250.00K

Top Sellers

Holder	Shares	% Assets	Change
Janus henderson group	150.82K	0.00%	-4.94M
Capital research global investors	-	-	-2.16M
Capital investors	-	-	-1.62M
Fil	-	-	-1.15M
Citadel advisors	-	-	-772.52K

New Positions

Holder	Shares	% Assets	Change	Value
Cormorant asset management, lp	175.00K	0.42%	175.00K	$8.44M
Davern capital partners, lp	126.46K	1.67%	126.46K	$6.10M
Octagon capital advisors lp	115.00K	0.49%	115.00K	$3.22M
Qube research	73.60K	0.00%	73.60K	$3.55M
Avidity partners management lp	48.00K	0.45%	48.00K	$1.99M

Sold Out

Holder	Change
Ima wealth	-2.00
Allworth financial lp	-9.00
Mai capital management	-10.00
Us bancorp \de\	-10.00
Global retirement partners	-10.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	202	-3.35%	67,558,659	1.26%	92	1.10%	105	-3.67%	55	-12.70%
Mar 31, 2026	87	-58.57%	6,488,710	-90.14%	10	0.09%	44	-64.23%	27	-57.81%
Dec 31, 2025	128	-26.86%	16,742,867	-70.45%	28	0.30%	73	-7.59%	37	-27.45%
Sep 30, 2025	45	-75.94%	2,773,848	-94.92%	14	0.16%	18	-82.86%	15	-63.41%
Jun 30, 2025	186	11.38%	54,608,579	-2.37%	94	99.54%	103	47.14%	42	-16.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Health Care Inv	2.91M	4.09%	-
American Century US Opport. Mid Cap Gr	967.35K	1.36%	199.68K
American Century Heritage Inv	967.35K	1.36%	199.68K
Worldwide Healthcare Ord	923.00K	1.29%	121.70K
Xtrackers MSCI USA Swap ETF 1C	837.23K	1.18%	837.23K
Fidelity Advisor Growth Opps M	733.50K	1.03%	-
Principal Glb Emerging Markets R5	625.75K	0.88%	-
Janus Henderson Hrzn Biotec E2 USD	581.26K	0.82%	16.04K
Vanguard Explorer Inv	577.22K	0.81%	-69.49K
Janus Henderson Global Life Sciences D	567.47K	0.80%	-1.89K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 01, 2026	Lin Xichen	CHIEF SCIENTIFIC OFFICER	Sell	-
Sep 01, 2026	Lin Xichen	CHIEF SCIENTIFIC OFFICER	Sell	-
Sep 01, 2026	Lin Xichen	CHIEF SCIENTIFIC OFFICER	Sell	-
Aug 18, 2026	Lin Xichen	CHIEF SCIENTIFIC OFFICER	Sell	-
Aug 18, 2026	Lin Xichen	CHIEF SCIENTIFIC OFFICER	Sell	-

Insider Transactions Trends

Date	Buy	Sell
2026 Q3	-	12
2026 Q2	-	3
2026 Q1	-	8
2025 Q4	-	10
2025 Q3	-	1

GPCR Ownership FAQ

Who Owns Structure Therapeutics?

Structure Therapeutics shareholders are primarily institutional investors at 92.99%, followed by 2.85% insiders and 4.16% retail investors. The average institutional ownership in Structure Therapeutics's industry, Biotech Stocks , is 379.01%, which Structure Therapeutics falls below.

Who owns the most shares of Structure Therapeutics?

Structure Therapeutics’s largest shareholders are Fmr (8.4M shares, 14.20%), Wellington management group llp (7.26M shares, 12.26%), and Avoro capital advisors (6.56M shares, 11.07%). Together, they hold 37.53% of Structure Therapeutics’s total shares outstanding.

Does Blackrock own Structure Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Structure Therapeutics.

Who is Structure Therapeutics’s biggest shareholder by percentage of total assets invested?

Bvf inc/il is Structure Therapeutics’s biggest shareholder by percentage of total assets invested, with 5.31% of its assets in 3.46M Structure Therapeutics shares, valued at 166.74M$.

Who is the top mutual fund holder of Structure Therapeutics shares?

Vanguard Health Care Inv is the top mutual fund holder of Structure Therapeutics shares, with 4.09% of its total shares outstanding invested in 2.91M Structure Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools